Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

Matt Darin comments on the cannabis industry, noting that form factors are relatively well-established, except possibly for beverages. He sees more opportunities for development and emphasizes the importance of a level playing field in the industry.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 8:01 pm

Matt Darin predicts significant global development in the coming years, with a particular emphasis on rapid growth in the Australia market and New Zealand. The Cannabis Capital Conference offers live access for existing and new subscribers to explore these trends further.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:44 pm

Matt Darin discussed the absence of 280E tax regulation in Europe, highlighting the advantage for cannabis companies in terms of cash flow and supply chain efficiency. He emphasized the unique opportunity to grow, process, manufacture, and distribute cannabis from a single point in Europe, contrasting it with the regulatory environment in other regions.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:34 pm

Curaleaf CEO Matt Darin announced at Benzinga's Cannabis Capital Conference that the company expanded into Europe three years ago, making it a core focus. He highlighted the international opportunity to scale globally and the capability to import/export cannabis.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 7:33 pm

Boris Jordan commented on President Biden's recent mention of cannabis in the State of the Union address, viewing it as a positive step for the cannabis industry. He suggests patience as things move in the right direction.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:28 pm

Boris Jordan emphasized the importance of market leaders in the cannabis industry to act as educators, highlighting the shift from a 50% medical business to a now predominantly adult-use driven market. He also noted that in Europe, the cannabis market is entirely medical. The article suggests watching the Cannabis Capital Conference live for more insights, indicating relevance for CURLF and MSOS investors.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:23 pm

Boris Jordan discussed the differences in consumer values towards THC between Europe and the U.S., noting that European values are not as prevalent as in the U.S. The U.S. is also experiencing a strategic shift in this context. The discussion was part of the Cannabis Capital Conference, accessible to subscribers and new users through provided links.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:23 pm

Boris Jordan, associated with Curaleaf, mentioned that following an acquisition in Canada, the company now has business operations in Australia and New Zealand. They are focusing on these markets to make Curaleaf's brands the most recognizable in the cannabis space.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:20 pm

Boris Jordan has announced the acquisition of a company to expand into the European market, focusing on EUGMP certified cannabis flowers and controlling the full supply chain for both flower and product sides. The announcement was made in the context of promoting the Cannabis Capital Conference, which offers live access for both existing and new subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:19 pm

Boris Jordan, associated with Curaleaf, highlights the medically driven European consumer market for cannabis, emphasizing the early stages of significant growth. Curaleaf stands out in the UK for offering a unique product range including flower, vapes, and gummies.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:18 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.